Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02365376
Other study ID # BMN 000-901
Secondary ID
Status Recruiting
Phase N/A
First received February 11, 2015
Last updated February 11, 2015
Start date June 2013

Study information

Verified date February 2015
Source BioMarin Pharmaceutical
Contact Evelyn Wang
Phone 415-506-6818
Email EWang@bmrn.com
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

The objective of this protocol is to enable collection of biospecimens to facilitate current and future multidisciplinary research in rare genetic disorders and medical conditions.


Recruitment information / eligibility

Status Recruiting
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Willing and able to provide written, signed informed consent

- Willing and able to comply with all study procedures

Exclusion Criteria:

- Use of any investigational product or investigational medical device within 30 days prior to screening, except as part of a BioMarin-sponsored study

- Concurrent disease or condition that would interfere with study participation or safety.

Study Design

Observational Model: Case-Only


Related Conditions & MeSH terms


Locations

Country Name City State
United States Lurie Children's Hospital of Chicago Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
BioMarin Pharmaceutical

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary continuous collection of donated study subject samples unknown, continuous sample collection No